New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
14:31 EDTAKRXAkorn sees FY13 adjusted EPS 57c-61c, consensus 66c
Sees FY13 revenue $325M-$335M, consensus $330.73M. The company's guidance excludes the impact from any products for which the company has not yet received FDA approval.
News For AKRX From The Last 14 Days
Check below for free stories on AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
07:54 EDTAKRXLeerink to hold a conference
Subscribe for More Information
September 19, 2014
14:18 EDTAKRXAkorn competition settlement over VersaPharm deal approved by FTC
Subscribe for More Information
September 15, 2014
07:10 EDTAKRXAkorn potential KUDCo deal makes strategic sense, says Piper Jaffray
Subscribe for More Information
September 12, 2014
09:00 EDTAKRXNeedham skeptical of potential Akorn deal for Kremers
Subscribe for More Information
September 11, 2014
12:56 EDTAKRXAkorn exploring 'inversion' deal for Belgian drugmaker unit, Reuters says
Subscribe for More Information
12:55 EDTAKRXAkorn pursuing potential inversion deal for UCB unit, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use